These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 16414329

  • 21. Estrogen with and without progestin: benefits and risks of short-term use.
    LaCroix AZ.
    Am J Med; 2005 Dec 19; 118 Suppl 12B():79-87. PubMed ID: 16414331
    [Abstract] [Full Text] [Related]

  • 22. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C.
    J Endocrinol Invest; 2005 Dec 19; 28(10 Suppl):80-4. PubMed ID: 16550729
    [Abstract] [Full Text] [Related]

  • 23. Update on continuous estrogen-progestin replacement therapy.
    Rosenfeld JA.
    Am Fam Physician; 1994 Nov 15; 50(7):1519-23, 1527-8. PubMed ID: 7976988
    [Abstract] [Full Text] [Related]

  • 24. Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy.
    Richman S, Edusa V, Fadiel A, Naftolin F.
    Menopause; 2006 Nov 15; 13(1):148-55. PubMed ID: 16607111
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F, Manson JE, Stampfer MJ.
    J Womens Health (Larchmt); 2006 Nov 15; 15(1):35-44. PubMed ID: 16417416
    [Abstract] [Full Text] [Related]

  • 36. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun 15; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

  • 37. Hormone replacement therapy in menopausal women: Past problems and future possibilities.
    Schmidt JW, Wollner D, Curcio J, Riedlinger J, Kim LS.
    Gynecol Endocrinol; 2006 Oct 15; 22(10):564-77. PubMed ID: 17135036
    [Abstract] [Full Text] [Related]

  • 38. Drug delivery systems for hormone therapy.
    Yoo JW, Lee CH.
    J Control Release; 2006 May 01; 112(1):1-14. PubMed ID: 16530874
    [Abstract] [Full Text] [Related]

  • 39. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society.
    Menopause; 2007 May 01; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.